Heartbeam Inc (BEAT)

Currency in USD
0.3955
-0.0082(-2.03%)
Closed·
0.3763-0.0192(-4.85%)
·
Advertisement
BEAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.36300.4046
52 wk Range
0.35504.0000
Key Statistics
Prev. Close
0.3955
Open
0.39
Day's Range
0.363-0.4046
52 wk Range
0.355-4
Volume
873.53K
Average Volume (3m)
7.37M
1-Year Change
-74.6474%
Book Value / Share
0.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.1250
Upside
+690.14%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Heartbeam Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.1250
(+690.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold---Maintain06/10/2026
H.C. Wainwright
Hold---Downgrade22/09/2026
Maxim Group
Buy2.00+405.69%-New Coverage14/07/2026
H.C. Wainwright
Buy2.50+532.11%5.50Maintain22/05/2026
Benchmark
Buy5.00+1,164.22%8.00Maintain15/05/2026

Heartbeam Inc Earnings Call Summary for Q3/2026

  • HeartBeam Q3 2026 net loss narrowed to $3.0M from $5.0M in Q2 and $5.3M year-ago; operating cash outflow fell 23% sequentially to $2.6M.
  • Operating expenses dropped 32% quarter-over-quarter to $3.5M; full-year 2026 cash burn guidance lowered to $12.0M-$12.5M from below $14.0M.
  • Company secured FDA Breakthrough Device designation and confirmed 510(k) pathway; pivotal 300-patient heart attack study enrollment expected Q1 2027.
  • Pro forma cash position stands at $10.1M after $4.0M ATM raise, extending runway into 2027; NASDAQ compliance discussions ongoing.
  • ALIGN-ACS data showed HeartBeam's 3D ECG matched 12-lead ECG diagnostic accuracy; pivotal study completion targeted for mid-2027.
Last Updated: 12/11/2026, 22:52
Read Full Transcript

Earnings

Latest Release
12/11/2026
EPS / Forecast
-0.05 / -0.09
Revenue / Forecast
25K / 112.5K
EPS Revisions
Last 90 days

Compare BEAT to Peers and Sector

Metrics to compare
BEAT
Peers
Sector
Relationship
P/E Ratio
−1.2x−1.1x−0.2x
PEG Ratio
−0.03−0.020.00
Price/Book
3.4x1.3x2.6x
Price / LTM Sales
-1.6x2.8x
Upside (Analyst Target)
-101.4%61.2%
Fair Value Upside
Unlock31.2%9.7%Unlock

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.23M5.73%1.28M
Other Institutional Investors
9.95M17.65%3.93M
Public Companies & Retail Investors
43.17M76.62%17.07M
Total
56.35M100.00%22.29M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Strome Investment Management, L.P.6.48%3,650,0001,444
Vanguard Capital Management, LLC4.28%2,412,330954

People Also Watch

1.6400
NCPL
-6.29%
0.2312
NIVF
-16.44%
0.6287
BENF
-3.71%
0.8907
AMOD
-3.86%
0.2223
GCTK
-7.38%

FAQ

What Is the Heartbeam (NASDAQ: BEAT) Share Price Today?

The Heartbeam stock price today is 0.3955 USD.

What Stock Exchange Does Heartbeam (BEAT) Trade On?

Heartbeam is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Heartbeam?

The stock symbol (also called a 'ticker') for Heartbeam is "BEAT."

What Is the Current Heartbeam Market Capitalisation?

As of today, Heartbeam (NASDAQ: BEAT) market cap is 22.2900M USD.

What Is Heartbeam's (BEAT) Earnings Per Share (TTM)?

The Heartbeam EPS is currently -0.39 (Trailing Twelve Months).

When Is the Next Heartbeam Earnings Date?

Heartbeam's next earnings report will be released on 18/03/2027.

Is BEAT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Heartbeam moving averages and other technical indicators, the daily buy/sell signal for BEAT stock is Strong Sell.

How Many Times Has Heartbeam Stock Split?

Heartbeam has split 0 times. (See the BEAT stock split history page for full effective split date and price information.)

How Many Employees Does Heartbeam Have?

Heartbeam has 16 employees, based on their latest Companies House report.

What is the current trading status of Heartbeam (NASDAQ: BEAT)?

As of 15/11/2026, Heartbeam (BEAT) is trading at a share price of 0.3955 USD, with a previous close of 0.3955 USD. The stock has fluctuated within a day range of 0.3630 USD to 0.4046 USD, while its 52-week range spans from 0.3550 USD to 4.0000 USD.

What Is Heartbeam (BEAT) Price Target According to Analysts?

The average 12-month price target for Heartbeam is 3.1250 USD, with a high estimate of 5 USD and a low estimate of 1.25 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +690.14% Upside potential.

What Is the BEAT Premarket Price?

BEAT's last pre-market stock price is 0.4010 USD. The pre-market share volume is 25,990.0000, and the stock has decreased by -0.0027, or -0.6700%.

What Is the BEAT After Hours Price?

BEAT's last after hours stock price is 0.3763 USD, the stock has decreased by -0.0192, or -4.8500%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.